» Articles » PMID: 18063838

Lung Lining Fluid Glutathione Attenuates IL-13-induced Asthma

Abstract

GGT(enu1) mice, deficient in gamma-glutamyl transferase and unable to metabolize extracellular glutathione, develop intracellular glutathione deficiency and oxidant stress. We used intratracheal IL-13 to induce airway inflammation and asthma in wild-type (WT) and GGT(enu1) mice to determine the effect of altered glutathione metabolism on bronchial asthma. WT and GGT(enu1) mice developed similar degrees of lung inflammation. In contrast, IL-13 induced airway epithelial cell mucous cell hyperplasia, mucin and mucin-related gene expression, epidermal growth factor receptor mRNA, and epidermal growth factor receptor activation along with airway hyperreactivity in WT mice but not in GGT(enu1) mice. Lung lining fluid (extracellular) glutathione was 10-fold greater in GGT(enu1) than in WT lungs, providing increased buffering of inflammation-associated reactive oxygen species. Pharmacologic inhibition of GGT in WT mice produced similar effects, suggesting that the lung lining fluid glutathione protects against epithelial cell induction of asthma. Inhibiting GGT activity in lung lining fluid may represent a novel therapeutic approach for preventing and treating asthma.

Citing Articles

Inhibition of γ-glutamyl transferase suppresses airway hyperresponsiveness and airway inflammation in a mouse model of steroid resistant asthma exacerbation.

Zhang C, Xu H, Netto K, Sokulsky L, Miao Y, Mo Z Front Immunol. 2023; 14:1132939.

PMID: 37377967 PMC: 10292800. DOI: 10.3389/fimmu.2023.1132939.


Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study.

Cho E, Jeong S, Chung G, Yoo J, Cho Y, Lee K Sci Rep. 2023; 13(1):1751.

PMID: 36720971 PMC: 9888340. DOI: 10.1038/s41598-022-25970-0.


The expression profile of lung long non-coding RNAs and mRNAs in a mouse model of smoke inhalation injury.

Jiang Z, Liu M, Fu Z, Liao X, Xu B, Shi L Bioengineered. 2022; 13(3):4978-4990.

PMID: 35152840 PMC: 8973775. DOI: 10.1080/21655979.2022.2037922.


Endoplasmic reticulum stress and glutathione therapeutics in chronic lung diseases.

Janssen-Heininger Y, Reynaert N, van der Vliet A, Anathy V Redox Biol. 2020; 33:101516.

PMID: 32249209 PMC: 7251249. DOI: 10.1016/j.redox.2020.101516.


Dysregulation of the glutaredoxin/glutathionylation redox axis in lung diseases.

Chia S, Elko E, Aboushousha R, Manuel A, van de Wetering C, Druso J Am J Physiol Cell Physiol. 2019; 318(2):C304-C327.

PMID: 31693398 PMC: 7052607. DOI: 10.1152/ajpcell.00410.2019.


References
1.
Rangasamy T, Guo J, Mitzner W, Roman J, Singh A, Fryer A . Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med. 2005; 202(1):47-59. PMC: 2212893. DOI: 10.1084/jem.20050538. View

2.
Christensen T, LUCEY E, Breuer R, Snider G . Acid-induced secretory cell metaplasia in hamster bronchi. Environ Res. 1988; 45(1):78-90. DOI: 10.1016/s0013-9351(88)80010-0. View

3.
Grunig G, Warnock M, Wakil A, Venkayya R, Brombacher F, Rennick D . Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282(5397):2261-3. PMC: 3897229. DOI: 10.1126/science.282.5397.2261. View

4.
Han L, Hiratake J, Kamiyama A, Sakata K . Design, synthesis, and evaluation of gamma-phosphono diester analogues of glutamate as highly potent inhibitors and active site probes of gamma-glutamyl transpeptidase. Biochemistry. 2007; 46(5):1432-47. DOI: 10.1021/bi061890j. View

5.
Marrades R, Roca J, Barbera J, de Jover L, MacNee W, Rodriguez-Roisin R . Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med. 1997; 156(2 Pt 1):425-30. DOI: 10.1164/ajrccm.156.2.9611001. View